Coeliac disease (CD) and CD autoimmunity (CDA) are immune-mediated conditions characterized by autoantibodies to tissue transglutaminase, affecting around 1% of the population worldwide with trends towards an increase in incidence in recent years [5,6,7]. Here, TGM2 is linked to congenital dyserythropoietic anemia.